Krystal Biotech Director Sells Nearly $5M in Shares as Company Posts Beat on Q4 Results
Dino A. Rossi, a director at Krystal Biotech, sold 18,950 shares of common stock on February 19, 2026, in two transactions totaling $4.95 million, and on the same day exercised options to acquire 18,950 shares at $8.79. The company reported fourth-quarter 2025 results that exceeded analyst forecasts for both EPS and revenue. The stock has risen 82%…